determin
signific
n
collagen
vascular
diseas
cvd
examin
activ
express
sera
diseas
site
patient
cvd
significantli
higher
aminopeptidas
activ
detect
bronchoalveolar
lavag
fluid
patient
interstiti
lung
diseas
due
rheumatoid
arthriti
ra
polymyositisdermatomyos
pmdm
system
sclerosi
ssc
syndrom
control
subject
increas
aminopeptidas
activ
increas
express
n
protein
found
alveolar
macrophag
cvd
patient
interstiti
lung
diseas
significantli
higher
aminopeptidas
activ
detect
pleural
effus
patient
system
lupu
erythematosu
sle
transud
effus
mean
aminopeptidas
activ
synovi
fluid
ra
patient
significantli
higher
patient
osteoarthr
mean
valu
serum
aminopeptidas
activ
significantli
higher
patient
sle
ra
ssc
pmdm
normal
subject
studi
suggest
activ
n
local
produc
diseas
site
use
marker
cvd
aminopeptidas
n
may
import
role
pathogenesi
cvd
keyword
aminopeptidas
n
ae
bronchoalveolar
lavag
ae
ae
collagen
vascular
diseas
pleural
effus
reagent
lleucineamc
purchas
peptid
institut
osaka
japan
monoclon
antibodi
human
purchas
becton
dickinson
san
jose
calif
usa
aminopeptidas
n
membranebound
metalloproteas
shown
ident
cell
surfac
glycoprotein
origin
use
marker
subpopul
hematopoiet
cell
n
wide
distribut
varieti
mammalian
cell
monocytesmacrophag
fibroblast
neutrophil
endotheli
cell
epitheli
cell
n
major
receptor
human
coronaviru
gastroenter
viru
import
role
hiv
entri
peptidas
shown
involv
degrad
extracellular
matrix
tumor
invas
process
peptid
present
antigenpres
cell
recent
report
n
chemotact
activ
lymphocyt
vitro
collagen
vascular
diseas
cvd
inflammatori
autoimmun
disord
affect
skin
joint
serou
membran
varieti
intern
organ
lung
kidney
heart
although
origin
shown
multifactori
involv
complex
interact
genet
environment
hormon
factor
precis
mechan
organ
inflamm
cvd
still
unclear
studi
examin
activ
n
patient
cvd
found
increas
activ
express
diseas
site
serum
suggest
import
role
pathogenesi
cvd
serum
sampl
serum
collect
patient
cvd
tabl
diagnosi
cvd
base
american
colleg
rheumatolog
criteria
cvd
patient
includ
system
lupu
erythematosu
sle
rheumatoid
arthriti
ra
ten
system
sclerosi
ssc
eight
polymyositisdermatomyos
pmdm
five
syndrom
sj
normal
volunt
consist
seven
young
doctor
none
show
abnorm
physic
examin
chest
radiographi
control
patient
free
collagen
vascular
diseas
four
mild
pulmonari
emphysema
three
diabet
mellitu
three
inact
gastric
ulcer
bronchoalveolar
lavag
bal
perform
patient
cvd
interstiti
pneumonia
cvdip
control
subject
patient
consist
eight
ra
three
men
year
old
six
ssc
two
men
year
old
six
pmdm
two
men
age
year
eight
sj
patient
one
man
age
year
control
consist
normal
volunt
men
age
year
control
patient
nine
men
age
year
none
normal
volunt
show
abnorm
physic
examin
chest
radiographi
lung
function
test
control
patient
free
interstiti
lung
diseas
local
lung
cancer
two
detect
lesion
lung
although
complain
hemosputum
bal
perform
describ
previous
briefli
flexibl
fiberopt
model
bronchoscop
olympu
tokyo
japan
wedg
segment
subsegment
bronchu
middl
lobe
lingula
lavag
perform
total
volum
ml
steril
salin
three
portion
lavag
fluid
gentli
aspir
syring
deep
inspir
fluid
recov
pass
steril
gauz
centrifug
g
min
precipit
cell
supernat
bal
fluid
balf
store
examin
precipit
cell
analyz
total
number
suspend
appropri
volum
salin
count
hemocytomet
differenti
count
cell
carri
smear
sediment
cell
stain
maygiemsa
stain
percentag
alveolar
macrophag
lymphocyt
neutrophil
eosinophil
calcul
cell
suspend
medium
plate
plate
white
maxisorp
nunc
denmark
densiti
cellswel
h
incub
co
nonadher
cell
remov
gentl
wash
aminopeptidas
activ
adher
measur
describ
pleural
effus
collect
via
diagnost
thoracentesi
patient
consist
five
sle
one
man
age
year
pleuriti
carcinomatosa
infecti
pleuriti
transud
pleural
effus
ten
men
age
year
pleuriti
carcinomatosa
due
primari
lung
cancer
adenocarcinoma
patient
men
age
year
ten
squamou
cell
carcinoma
patient
seven
men
age
year
ten
small
cell
lung
cancer
patient
eight
men
age
year
infecti
pleuriti
includ
nontubercul
pleuriti
men
age
year
nine
tubercul
pleuriti
patient
six
men
age
year
centrifug
g
min
cellfre
supernat
separ
store
examin
studi
done
patient
ra
nine
men
age
year
eight
osteoarthr
oa
five
men
age
year
patient
fulfil
american
rheumatoid
associ
criteria
diagnosi
definit
classic
ra
synovi
fluid
sampl
obtain
swollen
joint
patient
centrifug
g
min
supernat
store
test
proteas
activ
aminopeptidas
assay
fluorometr
describ
previous
brief
trishcl
buffer
ph
lleucineamc
dilut
buffer
sampl
ad
well
plate
white
maxisorp
nunc
denmark
standard
contain
variou
amount
amc
plate
incub
h
fluoresc
intens
measur
corona
electr
ibaragi
japan
nm
excit
nm
emiss
wavelength
aminopeptidas
activ
express
nanomol
substrat
cleav
per
h
bal
cell
dissolv
nissui
tokyo
japan
incub
falcon
tissu
cultur
dish
falcon
plastic
oxnard
calif
usa
humidifi
atmospher
co
min
plate
wash
three
time
pb
remov
nonadher
cell
adher
scrape
plate
use
cell
scraper
sumitomo
bakelit
osaka
japan
sonic
twice
khz
result
cell
lysat
mix
equal
volum
load
buffer
mm
trishcl
sodium
dodecyl
sulfat
sd
mgml
methyl
green
glycerol
fifti
microgram
protein
subject
polyacrylamid
gel
electrophoresi
sd
run
buffer
mm
trishcl
ph
mm
glycin
sd
electrophoresi
protein
band
transfer
immobilonp
membran
millipor
bedford
mass
usa
buffer
contain
mm
tri
ph
mm
glycin
sd
methanol
blot
pretreat
skim
milk
incub
antihuman
antibodi
primari
antibodi
biotinyl
antimurin
igg
secondari
antibodi
react
protein
visual
use
vectastain
abc
kit
vector
burlingam
calif
usa
accord
manufactur
instruct
phosphatebuff
solut
contain
tween
use
wash
buffer
throughout
blot
experi
result
express
statist
analysi
perform
use
student
twotail
unpair
ttest
comparison
two
group
correl
two
paramet
aminopeptidas
activ
measur
balf
patient
cvd
compar
normal
volunt
control
patient
cvd
patient
consist
eight
ra
six
ssc
six
pmdm
eight
sj
interstiti
lung
diseas
due
cvd
low
aminopeptidas
activ
detect
balf
normal
volunt
control
patient
nmolh
nmolh
respect
fig
hand
significantli
higher
patient
ra
ssc
pmdm
sj
signific
differ
diseas
group
aminopeptidas
activ
express
n
n
ectoenzym
locat
outer
cell
membran
variou
cell
monocyt
macrophag
determin
cellular
origin
aminopeptidas
balf
aminopeptidas
activ
patient
cvdip
measur
predomin
cell
alveolar
space
shown
fig
significantli
increas
aminopeptidas
activ
found
patient
cvdip
normal
volunt
next
express
n
protein
determin
western
blot
document
fig
lg
lysat
protein
separ
sd
polyacrylamid
gel
electrophoresi
sdspage
hand
lysat
protein
nine
patient
cvdip
contain
higher
amount
correspond
aminopeptidas
activ
balf
fig
level
aminopeptidas
activ
pleural
effus
measur
patient
sle
fig
found
significantli
higher
transud
effus
due
adenocarcinoma
smallcel
lung
cancer
squamou
cell
carcinoma
infecti
diseas
pleural
effus
sle
patient
also
significantli
higher
nontubercul
infect
adenocarcinoma
squamou
cell
carcinoma
small
cell
lung
cancer
respect
aminopeptidas
activ
synovi
fluid
patient
ra
eight
oa
shown
tabl
low
synovi
fluid
oa
patient
mean
valu
synovi
fluid
ra
patient
significantli
higher
oa
correl
significantli
number
lymphocyt
synovi
fluid
aminopeptidas
activ
sera
normal
subject
patient
cvd
shown
fig
low
sera
normal
volunt
control
patient
nmolh
nmolh
mean
activ
sera
patient
sle
ra
ssc
pm
dm
significantli
higher
nmolh
respect
normal
volunt
control
patient
individu
valu
vari
wide
show
increas
aminopeptidas
activ
sampl
diseas
site
balf
pleural
effus
synovi
fluid
patient
cvd
aminopeptidas
famili
mainli
consist
leucin
aminopeptidas
n
cystyl
aminopeptidas
lleucineamc
use
studi
substrat
detect
aminopeptidas
activ
could
cleav
leucin
aminopeptidas
aminopeptidas
n
cystyl
aminopeptidas
addit
cystyl
aminopeptidas
mainli
local
placent
lysosom
leucin
aminopeptidas
gener
locat
liver
optim
ph
degre
hand
n
locat
tissu
studi
optim
ph
neutral
ph
find
indic
increas
aminopeptidas
activ
diseas
site
cvd
may
predominantli
compos
n
balf
patient
cvdip
contain
higher
aminopeptidas
activ
control
subject
activ
macrophag
import
role
initi
amplifi
immunolog
inflammatori
respons
variou
inflammatori
lung
diseas
includ
cvdip
n
express
macrophag
shown
ectoenzym
marker
increas
macrophag
matur
becom
activ
studi
increas
activ
express
n
protein
found
patient
cvdip
indic
may
respons
aminopeptidas
activ
detect
balf
cvdip
patient
howev
n
also
report
express
fibroblast
neutrophil
endotheli
cell
studi
necessari
determin
cell
respons
aminopeptidas
balf
significantli
increas
activ
aminopeptidas
found
pleural
effus
due
sle
transud
effus
indic
aminopeptidas
local
produc
pleural
space
role
pleuriti
sle
higher
aminopeptidas
activ
also
detect
pleural
effus
due
adenocarcinoma
small
cell
carcinoma
though
significantli
lower
sle
patient
result
correspond
previou
report
show
n
express
cancer
cell
involv
tumor
cell
invas
extracellular
matrix
degrad
higher
aminopeptidas
activ
detect
synovi
fluid
ra
patient
oa
patient
n
express
varieti
cell
macrophag
express
peripher
blood
lymphocyt
shown
express
synovi
fluid
lymphocyt
studi
necessari
clarifi
cellular
origin
n
synovi
fluid
ra
patient
show
significantli
higher
aminopeptidas
activ
sera
patient
cvd
normal
volunt
control
patient
favaloro
et
al
show
serum
aminopeptidas
activ
could
mainli
ascrib
n
recent
report
increas
aminopeptidas
activ
detect
balf
patient
pulmonari
sarcoidosi
serum
level
higher
normal
control
therefor
increas
aminopeptidas
detect
serum
cvd
patient
may
repres
total
activ
n
gener
cvd
lesion
bodi
possibl
use
marker
cvd
diseas
activ
role
n
remain
unclear
recent
found
n
chemoattract
lymphocyt
enzymat
activ
requir
tcell
chemotact
activ
inhibit
result
abolish
chemotact
activ
result
suggest
enzymat
activ
n
role
migrat
lymphocyt
diseas
site
cvd
hand
n
known
present
cell
surfac
membranebound
enzym
cleav
ntermin
amino
acid
oligopeptid
recent
report
demonstr
increas
aminopeptidas
activ
urin
patient
diabet
nephropathi
carboplatininduc
renal
damag
treat
extracorpor
shock
wave
lithotripsi
activ
correl
extent
renal
damag
accordingli
proteolyt
activ
aminopeptidas
n
may
induc
degrad
structur
protein
result
tissu
inflamm
cvd
data
present
indic
n
activ
may
serv
marker
diagnosi
activ
cvd
suggest
n
may
particip
mechan
tissu
inflamm
disord
greater
understand
regul
product
action
enzym
may
lead
new
insight
control
treatment
cvd
